Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Shows potential in developing selective inhibitors for PIM kinases and FLT3, which are implicated in hematological malignancies. Also explored for its role in central nervous system agents due to structural affinity with neuroactive compounds. Currently investigated in preclinical studies for optimizing drug candidates with improved metabolic stability and target specificity.